share_log

Tracon Pharmaceuticals | EFFECT: Others

Tracon Pharmaceuticals | EFFECT: Others

Tracon Pharmaceuticals | EFFECT:其他
美股SEC公告 ·  11/04 06:05

Moomoo AI 已提取核心訊息

The United States Securities and Exchange Commission (SEC) has issued a Notice of Effectiveness for Tracon Pharmaceuticals, Inc. The notice, with an effectiveness date of November 1, 2024, was documented under accession number 0000950170-24-119575 and submission type POS AM. The SEC's formal declaration confirms the acceptance of Tracon Pharmaceuticals' filing, which is associated with file number 333-248593.
The United States Securities and Exchange Commission (SEC) has issued a Notice of Effectiveness for Tracon Pharmaceuticals, Inc. The notice, with an effectiveness date of November 1, 2024, was documented under accession number 0000950170-24-119575 and submission type POS AM. The SEC's formal declaration confirms the acceptance of Tracon Pharmaceuticals' filing, which is associated with file number 333-248593.
美國證券交易委員會(SEC)已經針對tracon pharmaceuticals公司發佈了有效通知。 該通知的生效日期爲2024年11月1日,文檔編號爲0000950170-24-119575,提交類型爲pos Am。 SEC的正式聲明確認了接受tracon pharmaceuticals提交的文件,與文件編號333-248593有關。
美國證券交易委員會(SEC)已經針對tracon pharmaceuticals公司發佈了有效通知。 該通知的生效日期爲2024年11月1日,文檔編號爲0000950170-24-119575,提交類型爲pos Am。 SEC的正式聲明確認了接受tracon pharmaceuticals提交的文件,與文件編號333-248593有關。
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息